Katherine D Franz, CNM | |
9000 W Sura Ln, Greenfield, WI 53228-3477 | |
(414) 466-8002 | |
Not Available |
Full Name | Katherine D Franz |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 9000 W Sura Ln, Greenfield, Wisconsin |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851763114 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Katherine D Franz, CNM 9000 W Sura Ln, Greenfield, WI 53228-3477 Ph: (414) 466-8002 | Katherine D Franz, CNM 9000 W Sura Ln, Greenfield, WI 53228-3477 Ph: (414) 466-8002 |
News Archive
The Washington Post: Since Congress passed the health overhaul, businesses that manage Medicaid "are rushing to get a foothold in states that outsource Medicaid. … But the experience in some states suggests pitfalls ahead. A recent report found that 2.7 million children on Medicaid in nine states, most of them states that outsource Medicaid, are not receiving required screenings and immunizations.
Marinomed Biotech AG, a globally operating biopharmaceutical company, is pleased to announce today that the Swansea University Medical School plans a clinical trial with Iota-/kappa-carrageenan nasal spray as a COVID-19 Prophylaxis for Healthcare Professionals (ICE-COVID).
Each year 2.5 million children die worldwide because they do not receive life-saving vaccinations at the appropriate time.
Demetrius H. Bagley, M.D., the Nathan Lewis Hatfield Professor of Urology in the Department of Urology at Jefferson Medical College (JMC) of Thomas Jefferson University was recently honored as the 2010 recipient of the Karl Storz Lifetime Achievement Award in Endourology at the World Congress of Endourology. He is also a full Professor of Radiology.
Repros Therapeutics Inc. today announced that the Company has received the FDA's version of the minutes of the Type C meeting held on January 25, 2010. The minutes confirmed the Company's interpretation of the points the Agency made during the meeting. In correspondence from the FDA prior to the meeting the Agency noted that they could not currently agree with the Company's stated indication for the use of Androxal® in the treatment of secondary hypogonadism in men wishing to preserve fertility.
› Verified 7 days ago
Chasity L Callender, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 9000 W Sura Ln, Greenfield, WI 53228 Phone: 414-246-6800 |